欢迎来到 登录 未经易推广诚信审核

武汉艾美捷科技有限公司

产品介绍

艾美捷人因子Ⅻ参数说明和文献参考

价 格:¥电议

型 号:

产品完善度:

生产地:其他访问量:0次

发布日期:2023/6/9 16:47:47

更新日期:2023/6/9 16:47:47

详细内容

 因子XIILOCARNO)是一种由基因序列异常引起的疾病。诊断和治疗需要采用分子诊断技术。艾美捷可提供致力找到病因、阻断遗传的基因解码和出于风险考虑的基因检测。

 

XIIa的抑制剂包括 C1-INH、α2-抗纤溶酶、α2-巨球蛋白和抗凝血酶 III。在生理浓度下,这些抑制剂的相对有效性分别为 91 : 4.5 : 3 : 1.5。 C1-INHXII的比例与因子VII的“冷激活”和血浆储存过程中肾素原向肾素的转化有关。人因子 XII是通过免疫亲和层析从新鲜冷冻血浆中制备的,并以50%(体积/体积)甘油/水的形式提供,可在-20℃下储存。

 

艾美捷人因子Ⅻ HCXII-0155相关参数:

Localization: 等离子

血浆浓度:40µg/ml3

作用方式:Zymogen;丝氨酸蛋白酶因子XIIa的体;

激肽释放酶/HMWK/阴离子表面复合物激活

阐明内在途径

分子量:800002

消光系数:E1 cm280 nm=14.0

等电点:6.8

结构:单链(Mr=80000),基于6个域组织

关于序列同源性(5

碳水化合物百分比:17%

 

Localization: Plasma

Plasma concentration: 40 µg/ml (3)

Mode of action: Zymogen; precursor to the serine protease factor XIIa;

activated by kallikrein/HMWK/anionic surface complex to

intitiate the intrinsic pathway

Molecular weight: 80,000 (2)

Extinction coefficient: E1 cm, 280 nm = 14.0

Isoelectric point: 6.8

Structure: single chain (Mr = 80,000), organized into 6 domains based

on sequence homology (5)

Percent carbohydrate: 17%

 

人因子Ⅻ HCXII-0155文献参考:

1. Schmaier, A.H., et al., in Hemostasis and Thrombosis, ed. R.W. Colman, J. Hirsh, V.J. Marder and

E.W. Salzman, pp 18-38, J.B. Lippincott Company, Philadelphia, 1987.

2. Griffin, J.H. and Cochrane, C.G., Methods Enzymol., 45, 56-65 (1976).

3. Saito, H., et al., J Lab Clin., 88, 506 (1976).

4. McMullen, B.A. and Fujikawa, N., J. Biol. Chem., 260, 5328 (1985).

5. Davie, E.W., in Hemostasis and Thrombosis, ed. R.W. Colman, J. Hirsh, V.J. Marder and E.W.

Salzman, pp 242-267, J.B. Lippincott Company, Philadelphia, 1987.

6. Griffin, J.H., Proc. Natl. Acad. Sci. USA, 75, 1998 (1978).

7. McMillin, L.R., et al., J. Clin. Invest., 54, 1312 (1974).

8. Revak, S.D., et al., J. Clin. Invest., 59, 1167 (1977).

9. Fujikawa, K., et al., Biochemistry, 16, 4182 (1977).

10. Bonno, N., et al., in New Comprehensive Biochemistry, ed. R.F.A. Zwaal and H.C.Hemker,

pp. 103-128, Elsevier, Amsterdam, 1986.

11. Claeys, H. and Collen, D. (1978) Eur. J. Biochem., 87, 69 (1978).

12. Revak, S.D. and Cochrane, C.G., J. Clin. Invest., 57, 852 (1976).

13. Cochrane, C.G., et al., J. Exp. Med., 138, 1564 (1973).

14. Revak, S.D., et al., J. Exp. Med., 147, 719 (1978).

15. Ghebrehiwet, B., et al., J. Clin. Invest., 71, 1458 (1983).

16. DeAgostini, A., et al., J. Clin. Invest., 73, 1542 (1984).

17. Rathoff, O.D., et al., J. Exp. Med., 129, 315 (1969).

18. Stead, N., et al., J. Biol Chem., 251, 6481 (1976).

19. Pixley, R.A., et al., J. Biol Chem., 260, 1723 (1985).

20. Gjonnass, H., Thromb. Diath. Haemorrh., 28, 182 (1972).

21. Radcliffe, R., et al., Blood, 59, 611 (1977).

 

来源:https://www.amyjet.com/products/HCXII-0155.shtml

提交询价

关闭